HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells

Oncotarget - United States
doi 10.18632/oncotarget.17950
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Differential Response of Cancer Cells to HDAC Inhibitors Trichostatin a and Depsipeptide

British Journal of Cancer
Cancer ResearchOncology
2011English

Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy With Immune Checkpoint Inhibitors

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
2018English

AurkA Inhibitors Enhance the Effects of B-Raf and MEK Inhibitors in Melanoma Treatment

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Effects of Novel HDAC Inhibitors on Urothelial Carcinoma Cells

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2018English

HDAC Inhibitors Impair FSHB Subunit Expression in Murine Gonadotrope Cells

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2019English

Enhancement of Transgene Expression by HDAC Inhibitors in Mouse Embryonic Stem Cells

Development & Reproduciton
2013English

Combining BET and HDAC Inhibitors Synergistically Induces Apoptosis of Melanoma and Suppresses AKT and YAP Signaling

Oncotarget
Oncology
2015English

Identification of HDAC Inhibitors Using a Cell-Based HDAC I/Ii Assay

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2016English

145 an in Vitro Model of Immunotherapy-Tolerant Melanoma Persister Cells

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy